Unique oral peptide delivery technology

Superior oral bioavailability compared to state-of-the-art peptide tablet technologies

Strong expertise and experience in oral delivery of GLP-1 peptides

Oral delivery of PROTACs and other Biopharmaceutics Classification System injectable (BCS Class IV) drugs

CYPRUMED | Oral Peptide Delivery Experts

Drug delivery technologies for the non-invasive administration of biologics. We are collaborating with various pharma partners, including Bayer, Boehringer Ingelheim and Ferring.

10+ years of experience

Unique technology

Collaborations with leading pharma companies

Patent protection and FTO

Areas of expertise

Cyprumed specializes in innovative oral delivery solutions for peptides such as GLP-1 agonists and Biopharmaceutics Classification System injectable (BCS Class IV) drugs, offering superior tablet formulations for enhanced bioavailability. With its team of experts and network, and its proprietary delivery platform, Cyprumed is at the forefront of the oral drug delivery technology industry. Cyprumed enables the transformation of novel peptides and BCS IV compounds into high-quality oral drug products.

Learn more

Cyprumed technology

The Cyprumed technology offers advantages over current delivery systems. We offer three oral drug delivery platforms: intestinal and gastric peptide delivery, and oral delivery of Biopharmaceutics Classification System injectable (BCS Class IV) drugs. By selecting the right delivery platform for your compound, we can make your API orally bioavailable.

Learn more

„Our technology is not only highly efficient, but also easy to produce and scale-up, while fulfilling key regulatory requirements.“
Florian Föger, PhD, CEO